Search Results 591-600 of 16936 for macronutrient optimization

  1. Experiential Pharmacogenomic Education for Providers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  3. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  4. Sugar Hyperabsorption Impact on Post-Bariatric Surgery Weight Loss Outcomes in African American Patients - Mayo Clinic

    About this study. The purpose of this study is to investigate glucose and fructose absorption in enteroids from obese African American subjects before and ...

  5. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  6. Prediction of Chronic Pacemaker/ICD Threshold by Increased Pulse Width Duration Pacing - Mayo Clinic

    The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse width) to the chronic pacing threshold of a pacemaker/ICD ...

  7. A world-class healthcare option - Mayo Clinic

    A team of nine specialists performed ground-breaking surgery which saved Janis Ollson's life. Read Janis' story. Share · Tweet . IMG-20404968.

  8. Efficacy And Safety Of Lubiprostone In Pediatric Subjects Aged ≥ 6 Years To < 18 Years With Functional Constipation - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  9. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  10. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...